Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company
Clinical trials sponsored by Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company, explained in plain language.
-
New hope for rare kidney disease: experimental drug tested in severe cases
Disease control Recruiting nowThis study tests an experimental drug called DCR-PHXC in 28 people with primary hyperoxaluria type 1 (PH1) who have severe kidney damage, whether or not they need dialysis. The goal is to see if the drug can safely lower oxalate levels in the blood, which may help control the dis…
Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
New cancer drug DCR-PDL1 enters first human safety tests
Disease control Recruiting nowThis early-stage study is testing a new drug called DCR-PDL1 in about 32 adults with solid tumors that have not responded to standard treatments. The main goal is to check the drug's safety and find the right dose by giving it through an IV and watching for side effects. This is …
Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC